These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18058636)

  • 1. [Cost-effectiveness of percutaneous core needle breast biopsy (CNBB) versus open surgical biopsy (OSB) of nonpalpable breast lesions: metaanalysis and cost evaluation for German-speaking countries].
    Gruber R; Bernt R; Helbich TH
    Rofo; 2008 Feb; 180(2):134-42. PubMed ID: 18058636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effective use of breast biopsy techniques in a Veterans health care system.
    Hatmaker AR; Donahue RM; Tarpley JL; Pearson AS
    Am J Surg; 2006 Nov; 192(5):e37-41. PubMed ID: 17071179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total cost comparison of 2 biopsy methods for nonpalpable breast lesions.
    Bodai BI; Boyd B; Brown L; Wadley H; Zannis VJ; Holzman M
    Am J Manag Care; 2001 May; 7(5):527-38. PubMed ID: 11388132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost comparison between ultrasound-guided 14-g large core breast biopsy and open surgical biopsy: an analysis for Austria.
    Gruber R; Walter E; Helbich TH
    Eur J Radiol; 2010 Jun; 74(3):519-24. PubMed ID: 19427153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of stereotactic 11-g vacuum-assisted breast biopsy on cost of diagnosis in Austria.
    Gruber R; Walter E; Helbich TH
    Eur J Radiol; 2011 Jan; 77(1):131-6. PubMed ID: 19853395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-core needle biopsy versus fine-needle aspiration biopsy in solid breast lesions: comparison of costs and diagnostic value.
    Vimpeli SM; Saarenmaa I; Huhtala H; Soimakallio S
    Acta Radiol; 2008 Oct; 49(8):863-9. PubMed ID: 18618302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficiency of Core Biopsy for BI-RADS-5 Breast Lesions.
    Wolf R; Quan G; Calhoun K; Soot L; Skokan L
    Breast J; 2008; 14(5):471-5. PubMed ID: 18821933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Are breast biopsies adequately funded? A process cost & revenue analysis].
    Hahn M; Fischbach E; Fehm T; Rothmund R; Siegmann KC; Scheich D; Heywang-Koebrunner SH; Jennissen JJ; Murauer M; Krapfl E; Landwehr P; Fronhoff K; Scheler P; Schreer I; Solomayer EF; Wallwiener D
    Rofo; 2011 Apr; 183(4):347-57. PubMed ID: 21113867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-guided vacuum assisted breast biopsy in the assessment of C3 breast lesions by ultrasound-guided fine needle aspiration cytology: results and costs in comparison with surgery.
    Abbate F; Bacigalupo L; Latronico A; Trentin C; Penco S; Menna S; Viale G; Cassano E; Bellomi M
    Breast; 2009 Apr; 18(2):73-7. PubMed ID: 19342236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core needle biopsy versus fine needle aspiration biopsy: are there similar sampling and diagnostic issues?
    Masood S
    Clin Lab Med; 2005 Dec; 25(4):679-88, vi. PubMed ID: 16308086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. US-guided core breast biopsy: use and cost-effectiveness.
    Liberman L; Feng TL; Dershaw DD; Morris EA; Abramson AF
    Radiology; 1998 Sep; 208(3):717-23. PubMed ID: 9722851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of stereotactic vacuum-assisted biopsy for nonpalpable breast lesions.
    Tsai HY; Huang ST; Chao MF; Kan JY; Hsu JS; Hou MF; Chiu HC
    Eur J Radiol; 2020 Jun; 127():108982. PubMed ID: 32334370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous large core needle biopsy versus surgical biopsy in the diagnosis of breast lesions.
    Anania G; Bazzocchi M; di Loreto C; Risaliti A; Terrosu G; Donini A; Zuiani C; Puglisi F; Bresadola F
    Int Surg; 1997; 82(1):52-5. PubMed ID: 9189803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Needle aspiration cytology of the breast: current perspective on the role in diagnosis and management].
    Kocjan G
    Acta Med Croatica; 2008 Oct; 62(4):391-401. PubMed ID: 19205416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost minimization analysis of ultrasound-guided diagnostic evaluation of probably benign breast lesions.
    Lee CI; Wells CJ; Bassett LW
    Breast J; 2013; 19(1):41-8. PubMed ID: 23186174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of ultrasound-guided liver biopsy.
    Pasha T; Gabriel S; Therneau T; Dickson ER; Lindor KD
    Hepatology; 1998 May; 27(5):1220-6. PubMed ID: 9581674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost minimization study of image-guided core biopsy versus surgical excisional biopsy for women with abnormal mammograms.
    Golub RM; Bennett CL; Stinson T; Venta L; Morrow M
    J Clin Oncol; 2004 Jun; 22(12):2430-7. PubMed ID: 15197205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing the cost of diagnosis of breast carcinoma: impact of ultrasound and imaging-guided biopsies on a clinical breast practice.
    Rubin E; Mennemeyer ST; Desmond RA; Urist MM; Waterbor J; Heslin MJ; Bernreuter WK; Dempsey PJ; Pile NS; Rodgers WH
    Cancer; 2001 Jan; 91(2):324-32. PubMed ID: 11180078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy.
    Groenewoud JH; Pijnappel RM; van den Akker-Van Marle ME; Birnie E; Buijs-van der Woude T; Mali WP; de Koning HJ; Buskens E
    Br J Cancer; 2004 Jan; 90(2):383-92. PubMed ID: 14735181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.